维普中文期刊产品整合服务
377篇 您的检索式:作者名="FLATT"
    题名 作者 年代 出处 被引量
1New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders显示文摘The applicability of stable gut hormones for the treatment of obesity-related diabetes is now undisputable. This is based predominantly on prominent and sustained glucoselowering actions, plus evidence that these peptides can augment insulin secretion and pancreatic islet function over time. This review highlights the therapeutic potential of glucagon-like peptide-1(GLP-1), glucose-dependent insulinotropic polypeptide(GIP), oxyntomodulin(OXM) and cholecystokinin(CCK) for obesity-related diabetes.Stable GLP-1 mimetics have already been successfully adopted into the diabetic clinic, whereas GIP, CCK and OXM molecules offer promise as potential new classes of antidiabetic drugs. Moreover, recent studies have shown improved therapeutic effects following simultaneous modulation of multiple receptor signalling pathways by combination therapy or use of dual/triple agonist peptides. However, timing and composition of injections may be important to permit interludes of beta-cell rest. The review also addresses the possible perils of incretin based drugs for treatment of prediabetes. Finally, the unanticipated utility of stable gut peptides as effective treatments for complications of diabetes, bone disorders, cognitive impairment and cardiovascular dysfunction is considered.Nigel Irwin Peter R Flatt 2015World Journal of Diabetes2015,6,15:4
2Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice显示文摘S. K. Swanston-Flatt C. Day C. J. Bailey P. R. Flatt 1990Diabetologia1990,,8:3
3Schizandra arisanensis extract attenuates cytokine-mediated cytotoxicity in insulin-secreting cells显示文摘AIM: To explore the bioactivity of an ethanolic extract of Schizandra arisanensis (SA-Et) and isolated constituents against interleukin-1 β and interferon-γ-mediated β cell death and abolition of insulin secretion. METHODS: By employing BRIN-BD11 cells, the effects of SA-Et administration on cytokine-mediated cell death and abolition of insulin secretion were evaluated by a viability assay, cell cycle analysis, and insulin assay. The associated gene and protein expressions were also measured. In addition, the bioactivities of several peak compounds collected from the SA-Et were tested against cytokine-mediated β cell death.RESULTS: Our Results revealed that SA-Et dose-dependently ameliorated cytokine-mediated β cell death and apoptosis. Instead of suppressing inducible nitric oxide synthase/nitric oxide cascade or p38MAPK activity, suppression of stress-activated protein kinase/c-Jun NH2-terminal kinase activity appeared to be the target for SA-Et against the cytokine mix. In addition, SA-Et provided some insulinotropic effects which re-activated the abolished insulin exocytosis in cytokine-treated BRIN-BD11 cells. Finally, schiarisanrin A and B isolated from the SA-Et showed a dose-dependent protective effect against cytokine-mediated β cell death. CONCLUSION: This is the first report on SA-Et ameliorating cytokine-mediated β cell death and dysfunction via anti-apoptotic and insulinotropic actions.Yi-Shin Hsu Yao-Haur Kuo Hui-Ling Cheng Peter R Flatt Hui-Kang Liu 2012World Journal of Gastroenterology2012,18,46:3
4The effects of traditional antidiabetic plants on in vitro glucose diffusion显示文摘A.M Gallagher P.R Flatt G Duffy Y.H.A Abdel-Wahab 2003Nutrition Research2003,,3:2
5Effects of ketone body infusion on hypoglyeemic reaetion in post absorptive dogs显示文摘Flatt J P Blackburn G L Randers G 1974Metabolism1974,23,:1
6Effect of dietary fat content on the inci- dence of obesity among ad libitum fed mice 显示文摘Salmon D M J P Flatt 1985Int J Obes1985,9,6:1
7Salt Damage in Porous Materials: How High Super Saturations are Generated显示文摘Flatt R J 2002Journal of Crystal Growth2002,242,34:1
8Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity显示文摘Pierce JP Stefanick ML Flatt SW 0,,17:1
9Concrete: An eco material that needs to be improved 显示文摘FLATT R J ROUSSEL N CHEESEMAN C R 2012J Eur Ceram Soe2012,32,11:1
10Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL)Study显示文摘Jacobs ET Thomson CA Flatt SW ctal 2011The American journal of clinical nutrition2011,93,1:1
11Compa-rison between ADCP and transmissometer measurements of suspended sedment concentration显示文摘HOLDAWAY G P THORNE P D FLATT D 0,,19:1
12Dietary factors affecting development of the ruminant stomach显示文摘Warner R G Flatt W P Loosli J K 1956J Agr Food Chem1956,4,:1
13Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes 显示文摘Green B D Flatt P R Bailey C J 2006Diabetes Vasc Dis Res2006,3,3:1
14Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the famesoid X receptor (FXR) 显示文摘Flatt B Martin R Wang TL 2009J Med Chem2009,52,:1
15Greater survival after breastcancer in physically active women with high vegetable-fruit intakeregardless of obesity显示文摘Pierce JP Stefanick ML Flatt SW 2007J Clin Oncol2007,25,17:1
16Tumor necrosis factor stimulates amylin secretion but inhibits insulin from islet β-cells by independent pathways显示文摘Ding X Z Flatt P R Adrian T E 1996Regulatory Peptides1996,64,3:1
17Failure of dietary fat intake to promote fat oxidation: a factor favoring the development of obesity显示文摘Schulz Y Flatt JP Jèquier E 1989Am J Clin Nutr1989,50,:1
18Greater survival afterbreast cancer in physically active women with high vegetable-fruit intake regardless of obesity 显示文摘Pierce JP Stefanick ML Flatt SW 2007J Clin Oncol2007,25,17:1
19Engineering cultured insulin-secreting pancreatic B-cell lines显示文摘McClenaghan NH Flatt PR 0,,01:1
20Four weeks administration of Limglufide improves memory and learning as well as glycaenic con trol in rricewith high fat dietary-induced obesity and insulin resistance显示文摘Porter DW Kerr M Flatt PR 0,,10:1
返回顶部 每页显示:
共19页 首页 上一页 第1页 下一页 末页 /19 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费